Intracoronary Imaging With NIRS-IVUS to Characterize Arterial Plaques
The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2012 by Spectrum Health Hospitals.
Recruitment status was Recruiting
Information provided by (Responsible Party):
Ryan Madder, MD, Spectrum Health Hospitals
First received: September 24, 2012
Last updated: October 5, 2012
Last verified: October 2012
To characterize atherosclerotic coronary artery plaques using advanced intra-coronary imaging with a combined near-infrared spectroscopy and intravascular ultrasound catheter before and after percutaneous intervention
||Time Perspective: Prospective
||Multimodality Advanced Intracoronary Imaging With Near-infrared Spectroscopy and Intravascular Ultrasound to Characterize Coronary Artery Plaques Before and After Percutaneous Intervention
| Estimated Enrollment:
| Study Start Date:
This study is being performed to characterize the composition and morphologic characteristics of atherosclerotic coronary artery plaques with intra-coronary near-infrared spectroscopy and intravascular ultrasound in patients undergoing percutaneous coronary intervention.
|Ages Eligible for Study:
||18 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
Coronary Artery Disease Patients
- Subject is at > 18 years of age
- Subject presents to the catheterization laboratory to undergo clinically-indicated, invasive coronary angiography
- Subject is willing and able to provide informed written consent
- Subject is found to have ≥ 1 severe coronary artery stenosis by invasive angiography and percutaneous coronary intervention is planned for definitive treatment or found to have ≥ 1 intermediate coronary artery stenosis and IVUS planned for lesion assessment
- Coronary anatomy is deemed suitable for combined NIRS-IVUS by the interventional cardiologist performing invasive angiography and intervention
- Subject is pregnant or suspected to be pregnant
- Subject is unable to provide informed consent
- Subject has coronary artery anatomy deemed by interventionalist as unsuitable for NIRS-IVUS
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01694368
|Spectrum Health; Frederik Meijer Heart &Vascular Institute
|Grand Rapids, Michigan, United States, 49503 |
|Contact: Stacie VanOosterhout, MEd 616-391-1162 email@example.com |
|Principal Investigator: Ryan D Madder, MD |
Spectrum Health Hospitals
No publications provided
||Ryan Madder, MD, Physician, Spectrum Health Hospitals
History of Changes
|Other Study ID Numbers:
|Study First Received:
||September 24, 2012
||October 5, 2012
||United States: Institutional Review Board
Keywords provided by Spectrum Health Hospitals:
Near infrared spectroscopy; lipid core plaque; vulnerable plaque.
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on October 21, 2014
Coronary Artery Disease
Arterial Occlusive Diseases